• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在模拟脑脊液浓度曲线的药效学模型中,头孢匹罗对来自脑膜炎患者的耐青霉素肺炎链球菌分离株的杀菌活性。

Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.

作者信息

Fitoussi F, Doit C, Sandin A, Pechinot A, Kazmierczack A, Geslin P, Bingen E

机构信息

Service de Microbiologie, Hôpital Robert Debré, Paris, France.

出版信息

Antimicrob Agents Chemother. 1995 Nov;39(11):2560-3. doi: 10.1128/AAC.39.11.2560.

DOI:10.1128/AAC.39.11.2560
PMID:8585745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC162984/
Abstract

An in vitro pharmacodynamic model was used to determine the killing kinetics of cefpirome against 20 Streptococcus pneumoniae strains (penicillin G MICs, > 0.125 to 2 micrograms/ml) isolated from patients with meningitis. The concentration of cefpirome was adjusted dynamically to simulate the median concentration profile obtained in the cerebrospinal fluid of adults after the infusion of a single dose of 2 g. The cefpirome MIC at which 90% of isolates are inhibited was 0.5 microgram/ml. Bactericidal activity was observed at 6 h, with mean killing of 3.51 +/- 0.34 log10 CFU/ml for all strains for which the cefpirome MIC was < 0.5 microgram/ml. In contrast, for strains for which the cefpirome MIC was > or = 0.5 microgram/ml, killing was significantly less (P < 0.05), with a mean reduction of only 2.86 +/- 0.57 log10 CFU/ml.

摘要

采用体外药效学模型来确定头孢匹罗对从脑膜炎患者分离出的20株肺炎链球菌(青霉素G的最低抑菌浓度,>0.125至2微克/毫升)的杀菌动力学。动态调整头孢匹罗的浓度,以模拟单剂量输注2克后在成人脑脊液中获得的中位浓度曲线。90%分离株被抑制时的头孢匹罗最低抑菌浓度为0.5微克/毫升。在6小时时观察到杀菌活性,对于头孢匹罗最低抑菌浓度<0.5微克/毫升的所有菌株,平均杀菌量为3.51±0.34 log10 CFU/毫升。相比之下,对于头孢匹罗最低抑菌浓度≥0.5微克/毫升的菌株,杀菌量明显较少(P<0.05),平均仅减少2.86±0.57 log10 CFU/毫升。

相似文献

1
Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.在模拟脑脊液浓度曲线的药效学模型中,头孢匹罗对来自脑膜炎患者的耐青霉素肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1995 Nov;39(11):2560-3. doi: 10.1128/AAC.39.11.2560.
2
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.美罗培南、亚胺培南、头孢曲松以及头孢曲松联合万古霉素在临床可达到的脑脊液浓度下对来自患脑膜炎儿童的耐青霉素肺炎链球菌分离株的体外比较杀菌活性。
Antimicrob Agents Chemother. 1998 Apr;42(4):942-4. doi: 10.1128/AAC.42.4.942.
3
Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.使用体外药效学模型评估头孢洛林对头孢洛林最低抑菌浓度(MIC)升高的青霉素中介型和青霉素耐药型肺炎链球菌临床分离株的活性。
J Antimicrob Chemother. 2012 Jul;67(7):1706-11. doi: 10.1093/jac/dks113. Epub 2012 Mar 30.
4
Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.在实验性脑膜炎中,头孢曲松与左氧氟沙星具有协同作用,并可降低左氧氟沙星诱导的耐青霉素肺炎球菌的耐药性。
J Antimicrob Chemother. 2004 Feb;53(2):305-10. doi: 10.1093/jac/dkh082. Epub 2004 Jan 16.
5
Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
J Antimicrob Chemother. 2002 Feb;49(2):327-30. doi: 10.1093/jac/49.2.327.
6
In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.头孢噻肟、头孢曲松和头孢唑肟对青霉素敏感、中介及耐药肺炎链球菌菌株的体外杀伤作用:杀菌和抑菌活性与脑脊液可达到水平的比较
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):35-42. doi: 10.1016/0732-8893(95)00094-q.
7
Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.对青霉素敏感性不同的肺炎链球菌菌株所致实验性脑膜炎的抗菌治疗
Antimicrob Agents Chemother. 1985 Feb;27(2):141-5. doi: 10.1128/AAC.27.2.141.
8
Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.对于对广谱头孢菌素中度敏感的肺炎链球菌所致脑膜炎,抗生素治疗及急性转归情况。
Antimicrob Agents Chemother. 1994 May;38(5):918-23. doi: 10.1128/AAC.38.5.918.
9
In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.肺炎链球菌菌株对九种β-内酰胺类抗生素的体外敏感性以及头孢菌素单独使用及与万古霉素或庆大霉素联合使用时的杀菌动力学。
Microb Drug Resist. 1996 Fall;2(3):361-9. doi: 10.1089/mdr.1996.2.361.
10
In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.头孢噻肟、头孢曲松、头孢他啶、头孢匹罗和青霉素对肺炎链球菌分离株的体外活性。
Antimicrob Agents Chemother. 1995 Oct;39(10):2193-6. doi: 10.1128/AAC.39.10.2193.

引用本文的文献

1
Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance.抗微生物药物的药代动力学和药效学参数:提供不易产生耐药性的给药方案的潜力。
Clin Pharmacokinet. 2009;48(8):517-28. doi: 10.2165/10895960-000000000-00000.
2
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.美罗培南、亚胺培南、头孢曲松以及头孢曲松联合万古霉素在临床可达到的脑脊液浓度下对来自患脑膜炎儿童的耐青霉素肺炎链球菌分离株的体外比较杀菌活性。
Antimicrob Agents Chemother. 1998 Apr;42(4):942-4. doi: 10.1128/AAC.42.4.942.
3
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.头孢匹罗。关于其抗菌活性、药代动力学特性及治疗严重医院感染和发热性中性粒细胞减少症临床疗效的综述。
Drugs. 1997 Jul;54(1):117-40. doi: 10.2165/00003495-199754010-00013.
4
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.采用棋盘法和时间杀菌法测定头孢匹罗和头孢噻肟单独及与万古霉素和替考拉宁联合使用时的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1996 Sep;40(9):1973-6. doi: 10.1128/AAC.40.9.1973.

本文引用的文献

1
Killing kinetics of cefuroxime against Streptococcus pneumoniae in an in vitro model simulating serum concentration profiles after intramuscular administration.在模拟肌内注射后血清浓度曲线的体外模型中头孢呋辛对肺炎链球菌的杀菌动力学
Eur J Clin Microbiol Infect Dis. 1993 Apr;12(4):297-9. doi: 10.1007/BF01967263.
2
Cefotaxime breakpoint for Streptococcus pneumoniae.肺炎链球菌的头孢噻肟断点值。
Antimicrob Agents Chemother. 1993 Mar;37(3):616-7. doi: 10.1128/AAC.37.3.616.
3
Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.耐头孢菌素肺炎链球菌脑膜炎的诊断与管理困境
Pediatr Infect Dis J. 1993 Mar;12(3):196-200. doi: 10.1097/00006454-199303000-00004.
4
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.用于治疗实验性耐青霉素和头孢菌素肺炎球菌脑膜炎的抗菌方案评估
Antimicrob Agents Chemother. 1993 Aug;37(8):1630-6. doi: 10.1128/AAC.37.8.1630.
5
Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.使用第三代头孢菌素治疗耐青霉素肺炎球菌性脑膜炎失败:病例报告及文献复习
Clin Infect Dis. 1994 Feb;18(2):188-93. doi: 10.1093/clinids/18.2.188.
6
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.耐抗生素肺炎链球菌所致感染的管理
N Engl J Med. 1994 Aug 11;331(6):377-82. doi: 10.1056/NEJM199408113310607.
7
In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.脑脊液中临床可达到浓度的抗生素对从脑膜炎患儿分离出的耐青霉素肺炎链球菌的体外杀伤活性。
Antimicrob Agents Chemother. 1994 Nov;38(11):2655-9. doi: 10.1128/AAC.38.11.2655.
8
Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.实验性肺炎球菌性脑膜炎:白细胞在发病机制中的作用
Infect Immun. 1983 Jul;41(1):275-9. doi: 10.1128/iai.41.1.275-279.1983.
9
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.兔实验性肺炎球菌性脑膜炎的杀菌与抑菌抗生素治疗
J Clin Invest. 1983 Mar;71(3):411-9. doi: 10.1172/jci110785.
10
Relatively penicillin-resistant pneumococcal infections in pediatric patients.小儿患者中相对耐青霉素的肺炎球菌感染
Pediatr Infect Dis. 1984 Mar-Apr;3(2):129-32. doi: 10.1097/00006454-198403000-00010.